ID   19X14
AC   CVCL_V060
SY   19 X 14
DR   CLO; CLO_0001144
DR   CLDB; cl27
DR   IHW; 11w 8010
DR   Wikidata; Q54582641
RX   PubMed=1692821;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; 914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; 4931; HLA-A (Note=Allele A*26).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 14
//
RX   PubMed=1692821; DOI=10.1016/0198-8859(90)90047-S;
RA   Zinszner H., Masset M., Bourge J.-F., Colombani J., Cohen D.,
RA   Degos L., Paul P.;
RT   "Nucleotide sequence of the HLA-A26 class I gene: identification of
RT   specific residues and molecular mapping of public HLA class I
RT   epitopes.";
RL   Hum. Immunol. 27:155-166(1990).
//